The Democratic National Committee is launching a new website today to show the impact of President Donald Trump’s tariffs and ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Some GOP lawmakers and pro-trade lobbyists are quietly seeking to rein in the most extreme elements of the Trump ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent ...

The EU as a whole has an annual trade surplus with the United States of $235.6 billion, according to the Bureau of Economic ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...